a
Company
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
MENU
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
CURRENT NEWS
26.01.2021
International Isotopes Inc. Comments on the Unusual Trading Volume and Share Price Volitility in Its Common Stock
26.01.2021
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
26.01.2021
Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women's Health Market
26.01.2021
Sandoz Canada Launches the First Generic Versions of Two Original Drugs: PrSandoz Posaconazole and PrSandoz Silodosin
26.01.2021
Helix Specialty Diagnostics Partners With Genomic LTC DX to Provide COVID-19 Testing With Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
26.01.2021
Inovalon Supports Centers for Medicare and Medicaid Services With Software Application for COVID-19 Vaccine Administration
26.01.2021
OraSure's OMNIgene·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program
26.01.2021
OPKO Health's BioReference Laboratories Team-Up With the National Basketball Association and National Hockey League to Provide Players and Staff With COVID-19 Testing
26.01.2021
Level 10 Construction Completes cGMP Manufacturing Space for TriLink Biotechnologies, an Important Component Supplier of COVID-19 Vaccines and Diagnostics
26.01.2021
UK Study Finds Antibiotics Azithromycin and Doxycycline Ineffective Against COVID-19
26.01.2021
AZ Refutes Reports Suggesting Its COVID-19 Vaccine Is Less Effective in the Elderly
26.01.2021
Aclipse Therapeutics Announces $2.2 Million Grant From UK's Medical Research Council for Development of M102
26.01.2021
Allarity Therapeutics to Test Activity of Its PARP Inhibitor, Stenoparib, as a Potential Therapy for New Highly Infectious Strain B.1.1.7 of Coronavirus
26.01.2021
OncoDNA Appoints Dr Bernard Courtieuas Chief Executive Officer
26.01.2021
New Data Show Treatment With Lilly's Neutralizing Antibodies Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent
26.01.2021
A Study in Which the VHIR Has Participated Discovers a New Pediatric Disease
26.01.2021
CommunityMed Offering Groundbreaking Rapid PCR COVID-19 Test
25.01.2021
2020 BPI Readers' Choice Award for “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A”
25.01.2021
Clarivate Launches Web of Science My Research Assistant Mobile Application
25.01.2021
CareDx Announces Closing of Public Offering of Common Stock
Records per page:
Page
Total:
24267
records.
×
How to see the list